129 related articles for article (PubMed ID: 33331187)
21. Imaging features (CT, MRI, MRS, and PET/CT) of primary central nervous system lymphoma in immunocompetent patients.
Cheng G; Zhang J
Neurol Sci; 2019 Mar; 40(3):535-542. PubMed ID: 30580380
[TBL] [Abstract][Full Text] [Related]
22. Reliability of fluorescein-assisted stereotactic brain biopsies in predicting conclusive tissue diagnosis.
Nevzati E; Chatain GP; Hoffman J; Kleinschmidt-DeMasters BK; Lillehei KO; Ormond DR
Acta Neurochir (Wien); 2020 Aug; 162(8):1941-1947. PubMed ID: 32291590
[TBL] [Abstract][Full Text] [Related]
23. Influence of preoperative corticosteroid treatment on rate of diagnostic surgeries in primary central nervous system lymphoma: a multicenter retrospective study.
Scheichel F; Marhold F; Pinggera D; Kiesel B; Rossmann T; Popadic B; Woehrer A; Weber M; Kitzwoegerer M; Geissler K; Dopita A; Oberndorfer S; Pfisterer W; Freyschlag CF; Widhalm G; Ungersboeck K; Roessler K
BMC Cancer; 2021 Jun; 21(1):754. PubMed ID: 34187419
[TBL] [Abstract][Full Text] [Related]
24. Case report of an elderly woman with atypical imaging for primary central nervous system lymphoma who needed a brain biopsy for diagnosis.
Matsuzono K; Yagisawa T; Ohtani K; Ishishita Y; Yamaguchi T; Mashiko T; Ozawa T; Koide R; Tanaka R; Kawai K; Fujimoto S
J Int Med Res; 2021 Aug; 49(8):3000605211035197. PubMed ID: 34461767
[TBL] [Abstract][Full Text] [Related]
25. Differentiation of high-grade glioma and primary central nervous system lymphoma: Multiparametric imaging of the enhancing tumor and peritumoral regions based on hybrid
Zhang S; Wang J; Wang K; Li X; Zhao X; Chen Q; Zhang W; Ai L
Eur J Radiol; 2022 May; 150():110235. PubMed ID: 35290912
[TBL] [Abstract][Full Text] [Related]
26. Atypical primary central nervous system lymphoma and glioblastoma: multiparametric differentiation based on non-enhancing volume, apparent diffusion coefficient, and arterial spin labeling.
Yu X; Hong W; Ye M; Lai M; Shi C; Li L; Ye K; Xu J; Ai R; Shan C; Cai L; Luo L
Eur Radiol; 2023 Aug; 33(8):5357-5367. PubMed ID: 37171492
[TBL] [Abstract][Full Text] [Related]
27. 5-Aminolaevulinic Acid-Induced Fluorescence in Primary Central Nervous System Lymphoma.
Evers G; Kamp M; Warneke N; Berdel W; Sabel M; Stummer W; Ewelt C
World Neurosurg; 2017 Feb; 98():375-380. PubMed ID: 27838426
[TBL] [Abstract][Full Text] [Related]
28. Ultrasound-based real-time neuronavigated fluorescence-guided surgery for high-grade gliomas: technical note and preliminary experience.
Villa A; Costantino G; Meli F; Odierna Contino A; Imperato A; Francaviglia N
Acta Neurochir (Wien); 2019 Dec; 161(12):2595-2605. PubMed ID: 31656986
[TBL] [Abstract][Full Text] [Related]
29. Real-time Magnetic Resonance Imaging-Guided Biopsy Using SmartFrame® Stereotaxis in the Setting of a Conventional Diagnostic Magnetic Resonance Imaging Suite.
Scheer JK; Hamelin T; Chang L; Lemkuil B; Carter BS; Chen CC
Oper Neurosurg (Hagerstown); 2017 Jun; 13(3):329-337. PubMed ID: 28521346
[TBL] [Abstract][Full Text] [Related]
30. Central nervous system lymphoma: a morphological MRI study.
Koubska E; Weichet J; Malikova H
Neuro Endocrinol Lett; 2016 Sep; 37(4):318-324. PubMed ID: 27857050
[TBL] [Abstract][Full Text] [Related]
31. Fluorescein sodium-guided resection of a cerebellar lymphoma: case report and literature review.
Franzini A; Zekaj E; Bona A; Ciuffi A; Porta M; Servello D
Br J Neurosurg; 2023 Aug; 37(4):671-674. PubMed ID: 30681012
[TBL] [Abstract][Full Text] [Related]
32. Role of intra-tumoral vasculature imaging features on susceptibility weighted imaging in differentiating primary central nervous system lymphoma from glioblastoma: a multiparametric comparison with pathological validation.
Bhattacharjee R; Gupta M; Singh T; Sharma S; Khanna G; Parvaze SP; Patir R; Vaishya S; Ahlawat S; Singh A; Gupta RK
Neuroradiology; 2022 Sep; 64(9):1801-1818. PubMed ID: 35435463
[TBL] [Abstract][Full Text] [Related]
33. What is the Best Preoperative Quantitative Indicator to Differentiate Primary Central Nervous System Lymphoma from Glioblastoma?
Inoue A; Matsumoto S; Ohnishi T; Miyazaki Y; Kinnami S; Kanno K; Honda T; Kurata M; Taniwaki M; Kusakabe K; Suehiro S; Yamashita D; Shigekawa S; Watanabe H; Kitazawa R; Kunieda T
World Neurosurg; 2023 Apr; 172():e517-e523. PubMed ID: 36690204
[TBL] [Abstract][Full Text] [Related]
34. Primary cerebral lymphoma: the "ghost tumor". Case report.
Vaquero J; Martínez R; Rossi E; López R
J Neurosurg; 1984 Jan; 60(1):174-6. PubMed ID: 6689712
[TBL] [Abstract][Full Text] [Related]
35. Combination of 5-ALA and iMRI in re-resection of recurrent glioblastoma.
Quick-Weller J; Lescher S; Forster MT; Konczalla J; Seifert V; Senft C
Br J Neurosurg; 2016 Jun; 30(3):313-7. PubMed ID: 26743016
[TBL] [Abstract][Full Text] [Related]
36. Tumor detection with 5-aminolevulinic acid fluorescence and Gd-DTPA-enhanced intraoperative MRI at the border of contrast-enhancing lesions: a prospective study based on histopathological assessment.
Coburger J; Engelke J; Scheuerle A; Thal DR; Hlavac M; Wirtz CR; König R
Neurosurg Focus; 2014 Feb; 36(2):E3. PubMed ID: 24484256
[TBL] [Abstract][Full Text] [Related]
37. [Effectiveness of intraoperative fluorescence for diagnosis of malignant lymphoma].
Okuda T; Kataoka K; Kato A
No Shinkei Geka; 2008 Nov; 36(11):1001-4. PubMed ID: 19048918
[TBL] [Abstract][Full Text] [Related]
38. Differentiation of primary central nervous system lymphoma from high-grade glioma and brain metastasis using arterial spin labeling and dynamic contrast-enhanced magnetic resonance imaging.
Xi YB; Kang XW; Wang N; Liu TT; Zhu YQ; Cheng G; Wang K; Li C; Guo F; Yin H
Eur J Radiol; 2019 Mar; 112():59-64. PubMed ID: 30777220
[TBL] [Abstract][Full Text] [Related]
39. Clinical application of 3.0 T intraoperative magnetic resonance combined with multimodal neuronavigation in resection of cerebral eloquent area glioma.
Lu CY; Chen XL; Chen XL; Fang XJ; Zhao YL
Medicine (Baltimore); 2018 Aug; 97(34):e11702. PubMed ID: 30142758
[TBL] [Abstract][Full Text] [Related]
40. Incidence and radiographic findings of primary central nervous system lymphoma in immunocompetent patients in southern Thailand.
Rujirojindakul P; Rohitoprakarn M; Kongkabpan D; Viboonjantra P; Lekhakula A
Tumori; 2008; 94(3):304-8. PubMed ID: 18705395
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
